Results 231 to 240 of about 371,850 (309)

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta   +5 more
wiley   +1 more source

A qualitative study of Yorùbá culture and the utilisation of modern dental services for oral health. [PDF]

open access: yesBMC Health Serv Res
Folayan MO   +16 more
europepmc   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden   +3 more
wiley   +1 more source

Investing in traditional medicine: leveraging evidence and innovative research to strengthen the fight against malaria in Nigeria. [PDF]

open access: yesMalar J
Onukansi FO   +10 more
europepmc   +1 more source

Remedying a Legal Black Hole

open access: yesGoettingen Journal of International Law
openaire   +1 more source

Sex testing in women's sport: historical harms, contemporary risks, and World Athletics' 2025 policy shift. [PDF]

open access: yesFront Sports Act Living
Camporesi S   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy